These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Is there a problem with ezetimibe or just ENHANCEd hype? Whayne TF Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445 [No Abstract] [Full Text] [Related]
3. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe. Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996 [No Abstract] [Full Text] [Related]
4. ENHANCE: food for the ostriches. Jackson G Int J Clin Pract; 2008 May; 62(5):667-8. PubMed ID: 18412925 [No Abstract] [Full Text] [Related]
5. In brief: Zetia and Vytorin: the ENHANCE study. Med Lett Drugs Ther; 2008 Jan; 50(1278):5. PubMed ID: 18219263 [No Abstract] [Full Text] [Related]
6. [Commentary to the article: Kastelein JJ, Akdim F, Stroes ES, et al.; ENHANCE Investigators. Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008; 358: 1431-43 ]. MichaĆek A Kardiol Pol; 2008 May; 66(5):597-8, discussion 598-9. PubMed ID: 18630396 [No Abstract] [Full Text] [Related]
7. ["The lower LDL cholesterol levels, the better" still valid. Negative/neutral conclusions of three studies on statins do not change the clinical practice]. Olsson AG; Nilsson PM Lakartidningen; 2009 Mar 18-24; 106(12):854-7. PubMed ID: 19452786 [No Abstract] [Full Text] [Related]
9. Simvastatin with or without ezetimibe in familial hypercholesterolemia. Kaye T N Engl J Med; 2008 Jul; 359(5):531-2; author reply 532-3. PubMed ID: 18677800 [No Abstract] [Full Text] [Related]
10. [Approved indication for Ezetrol]. Eriksson N; Phillipson T Lakartidningen; 2005 Mar 14-20; 102(11):887. PubMed ID: 15835530 [No Abstract] [Full Text] [Related]
12. Simvastatin with or without ezetimibe in familial hypercholesterolemia. Eichhorn EJ N Engl J Med; 2008 Jul; 359(5):529-30; author reply 532. PubMed ID: 18677795 [No Abstract] [Full Text] [Related]
13. Simvastatin with or without ezetimibe in familial hypercholesterolemia. Connor WE N Engl J Med; 2008 Jul; 359(5):530; author reply 532-3. PubMed ID: 18677797 [No Abstract] [Full Text] [Related]
14. Simvastatin with or without ezetimibe in familial hypercholesterolemia. Blake JA N Engl J Med; 2008 Jul; 359(5):531; author reply 532-3. PubMed ID: 18677798 [No Abstract] [Full Text] [Related]
15. Critical lessons from the ENHANCE trial. Greenland P; Lloyd-Jones D JAMA; 2008 Feb; 299(8):953-5. PubMed ID: 18314439 [No Abstract] [Full Text] [Related]
16. Simvastatin with or without ezetimibe in familial hypercholesterolemia. Davis HR; Murgolo NJ; Graziano MP N Engl J Med; 2008 Jul; 359(5):531; author reply 532-3. PubMed ID: 18677799 [No Abstract] [Full Text] [Related]
17. The ENHANCE study and marketing ezetimibe. Akdim F; Kastelein JJ; Gaudet D JAMA; 2008 Jun; 299(23):2747; author reply 2747-8. PubMed ID: 18560001 [No Abstract] [Full Text] [Related]
18. [Dual lipid control without anti-atherosclerosis effect]. Einecke D MMW Fortschr Med; 2008 Apr; 150(16):18, 20. PubMed ID: 18557109 [No Abstract] [Full Text] [Related]
19. LDL-Cholesterol is the King. Goumas GS Angiology; 2009; 60(3):387-8. PubMed ID: 19497926 [No Abstract] [Full Text] [Related]
20. [Ezetimib--inhibitor of cholesterol absorption: new perspectives in the treatment of dyslipidemia]. Susekov AV Ter Arkh; 2005; 77(8):24-9. PubMed ID: 16206601 [No Abstract] [Full Text] [Related] [Next] [New Search]